{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:35:04Z","timestamp":1790634904218,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.jri.2009.04.002","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T12:00:30Z","timestamp":1244635230000},"page":"34-38","source":"Crossref","is-referenced-by-count":32,"title":["CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa"],"prefix":"10.1016","volume":"81","author":[{"given":"Kelly A.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Beagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2009.04.002_bib1","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3083.2005.01713.x","article-title":"The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization","volume":"63","author":"Akhiani","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2007.12.048","article-title":"In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia NrdB","volume":"26","author":"Barker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0378(00)00069-3","article-title":"Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development","volume":"48","author":"Beagley","year":"2000","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0264-410X(02)00043-9","article-title":"The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant","volume":"20","author":"Choi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0897.2008.00637.x","article-title":"Poly-immunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infection","volume":"60","author":"Cunningham","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1095\/biolreprod.108.067835","article-title":"Male genital tract chlamydial infection: implications for pathology and infertility","volume":"79","author":"Cunningham","year":"2008","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2009.04.002_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jri.2009.04.002_bib10","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib11","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/515286","article-title":"Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization","volume":"177","author":"Gallichan","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jri.2009.04.002_bib13","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.vaccine.2004.04.021","article-title":"Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate","volume":"22","author":"Hickey","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib14","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Igietseme","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jri.2009.04.002_bib15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/CVI.00274-07","article-title":"Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach","volume":"14","author":"Li","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jri.2009.04.002_bib16","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1016\/j.vaccine.2007.05.065","article-title":"Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge","volume":"25","author":"McNeal","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib17","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.vaccine.2006.12.019","article-title":"Expression library immunization confers partial protection against Chlamydia muridarum genital infection","volume":"25","author":"McNeilly","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jri.2009.04.002_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.vaccine.2005.08.074","article-title":"Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge","volume":"24","author":"Pal","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jri.2009.04.002_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3201\/eid0204.960406","article-title":"Chlamydiae as pathogens: new species and new issues","volume":"2","author":"Peeling","year":"1996","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jri.2009.04.002_bib21","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1086\/513844","article-title":"Chlamydia trachomatis infections: progress and problems","volume":"179","author":"Stamm","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jri.2009.04.002_bib22","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1099\/vir.0.2008\/005470-0","article-title":"CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization","volume":"89","author":"Sundling","year":"2008","journal-title":"J. Gen. Virol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037809000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037809000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T16:45:15Z","timestamp":1685033115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037809000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0165037809000801"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2009.04.002","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}